Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $38
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $35 to $38.
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $35 to $38.